CVS HEALTH CORPORATION Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3
CVS HEALTH CORPORATION (CVS) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 of $23.00 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-10-29.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 · last filed 2025-10-29
- CVS HEALTH CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2025-09-30 was $23.00M, a 51.06% decline year-over-year.
- CVS HEALTH CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2025-06-30 was $19.00M.
- CVS HEALTH CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2025-03-31 was $13.00M.
- CVS HEALTH CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2024-09-30 was $47.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 9 month |
|---|---|---|---|
| 2025-09-30 | $23.00M 10-Q · filed 2025-10-29 | $42.00M derived: sum of 2 quarters · filed 2025-10-29 | $55.00M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $19.00M 10-Q · filed 2025-07-31 | $32.00M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $13.00M 10-Q · filed 2025-05-01 | ||
| 2024-09-30 | $47.00M 10-Q · filed 2025-10-29 | $47.00M derived: sum of 2 quarters · filed 2025-10-29 | $47.00M 10-Q · filed 2025-10-29 |
| 2024-06-30 | $0.00 10-Q · filed 2025-07-31 | $0.00 10-Q · filed 2025-07-31 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-01 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-06 | $13.00M derived: sum of 2 quarters · filed 2024-11-06 | $42.00M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $13.00M 10-Q · filed 2024-08-07 | $42.00M 10-Q · filed 2024-08-07 | |
| 2023-03-31 | $29.00M 10-Q · filed 2024-05-01 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-01 | $26.00M derived: sum of 2 quarters · filed 2023-11-01 | $29.00M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $26.00M 10-Q · filed 2023-08-02 | $29.00M 10-Q · filed 2023-08-02 | |
| 2022-03-31 | $3.00M 10-Q · filed 2023-05-03 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-03 | $0.00 10-Q · filed 2022-08-03 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |